دورية أكاديمية

Closed-Loop Oxygen Control Using a Novel Nasal High-Flow Device: A Randomized Crossover Trial.

التفاصيل البيبلوغرافية
العنوان: Closed-Loop Oxygen Control Using a Novel Nasal High-Flow Device: A Randomized Crossover Trial.
المؤلفون: Harper, James CP, Kearns, Nethmi A., Maijers, Ingrid, Bird, Grace E., Braithwaite, Irene, Shortt, Nicholas P., Eathorne, Allie, Weatherall, Mark, Beasley, Richard
المصدر: Respiratory Care; Mar2021, Vol. 66 Issue 3, p416-424, 9p
مصطلحات موضوعية: HUMAN research subjects, CONFIDENCE intervals, OXYGEN consumption, HEALTH outcome assessment, REGRESSION analysis, ARTIFICIAL respiration, RANDOMIZED controlled trials, INFORMED consent (Medical law), OXYGEN therapy, BLIND experiment, DESCRIPTIVE statistics, STATISTICAL sampling, CROSSOVER trials, PULSE oximeters, DATA analysis software
مستخلص: BACKGROUND: Oxygen administration is recommended for patients with hypoxemia to achieve a target ... range. Strategies to achieve this in clinical practice are suboptimal. We investigated automatic oxygen titration using a novel nasal high-flow device with closed-loop oxygen control. The objective of this proof-of-concept study was to determine whether closed-loop control was able to respond to desaturation and subsequent recovery in a controlled laboratory-based environment. METHODS: We conducted a single-blind randomized crossover trial in adults with chronic respiratory disease who had a resting ... ≥ 92% and desaturated to < 90% during a 6-min walk test (6MWT). Nasal high-flow was administered during a 6MWT and a subsequent 10-min rest period with either room air, a fixed concentration of 28% oxygen, or oxygen titrated automatically using closed-loop control. RESULTS: The study involved 42 subjects. Closed-loop control maintained ... within the target range of 92-96% for a mean (SD) duration of 54.4 ± 30.1% of the 6MWT and 67.3 ± 26.8% of the recovery period. The proportion of time spent with an ... in the target range during the 6MWT was significantly greater for closed-loop control compared to room air, with a difference of 26.0% (95% CI 17.7-34.2, P < .001); this proportion of time was not significantly different compared to the fixed concentration of 28% oxygen, with a difference of -8.2% (95% CI -16.5 to 0.1, P = .052). The proportion of time spent in the target range during the rest period was significantly greater compared to 28% oxygen, with a difference of 19.3% (95% CI 8.9-29.7, P < .001); this proportion of time was not significantly different compared to room air, with a difference of -9.3% (95% CI -19.7 to 1.0, P = .08). CONCLUSIONS: This study provides proof-of-concept evidence that the novel nasal high-flow device with closed-loop control can respond to changes in ... outside a target saturation range using a model of exercise-induced desaturation and subsequent recovery. [ABSTRACT FROM AUTHOR]
Copyright of Respiratory Care is the property of American Association for Respiratory Care and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:00201324
DOI:10.4187/respcare.08087